Why on earth would the company want to raise cash at 70c? They have a compound entering final approval (synthetic heparin) a compound about to enter phase III trials (HyCAMP) which validates a platform technology, a compound (HyFIVE) completed phase I trials and a platfrm technology in discovery (VAST). What other biotech in Australia has such a rich pipeline? I am sure they would want to be raising capital at >$1.40 if they can and will be pulling out all stops to achieve that. Talking them down makes no sence at all.
where are they now, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable